Qualitative interview
Otheranalysis of interview data using the IPSE (Inductive Process to analyze the Structure of lived Experience) method
NCT Number: NCT07499934
The goal of this qualitative study is to explore and describe the lived experiences of individuals at ultra-high risk (UHR) or first episode of psychosis (FEP) who have participated in a group-based mindfulness-based intervention. Secondary objectives include identifying potential adverse effects of a group-based mindfulness-based intervention among UHR or FEP.
Interested in participating?
Request Info15 year–30 year
All sexes
Interventional
Not applicable
Centre Psychothérapique de Nancy, Laxou, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
analysis of interview data using the IPSE (Inductive Process to analyze the Structure of lived Experience) method
Time frame: The qualitative interview takes place between one week and three months after the final session of the mindfulness-based program
To explore and describe the lived experiences of individuals with UHR or FEP who have participated in a group-based mindfulness intervention using the IPSE method.
Contact information is provided by the study sponsor or research team.
Centre Psychothérapique de Nancy
Other
Acronym: EMIP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06649552
Clinical High Risk for Psychosis (CHR), Mental Disorders
Lille, France
View Trial DetailsNCT06870305
Clinical High Risk for Psychosis (CHR), Mental Disorders
Brest, France
View Trial DetailsNCT07434973
Clinical High Risk for Developing Psychosis, Clinical High Risk for Psychosis
Vienna, Austria
View Trial DetailsNCT07226895
Clinical High Risk for Psychosis (CHR)
Irvine, California, United States
View Trial Details